Related Experiment Video
Updated: May 2, 2026

Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes
Published on: June 3, 2018
Small molecules enable cardiac reprogramming of mouse fibroblasts with a single factor, Oct4
Haixia Wang1, Nan Cao1, C Ian Spencer1
1Gladstone Institute of Cardiovascular Disease, San Francisco, CA 94158, USA; Roddenberry Center for Stem Cell Biology and Medicine at Gladstone, San Francisco, CA 94158, USA.
Scientists developed a small-molecule cocktail to reprogram mouse fibroblasts into cardiac cells. This method uses only one transcription factor, Oct4, reducing genetic manipulation for potential cell therapies and cardiac regeneration.
Area of Science:
- * Regenerative Medicine
- * Molecular Biology
- * Cardiology
Background:
- * Fibroblast reprogramming to cardiac cells typically requires multiple genetic manipulations.
- * Reducing genetic interventions is crucial for therapeutic applications like cell-based therapy and in vivo cardiac regeneration.
- * Small molecules offer a promising alternative to genetic factors for cell fate conversion.
Purpose of the Study:
- * To identify a small-molecule cocktail for efficient cardiac reprogramming of fibroblasts.
- * To investigate if this reprogramming can be achieved with minimal genetic factors, specifically one transcription factor.
- * To assess the characteristics and developmental stage of the induced cardiac cells.
Main Methods:
- * Screening of small-molecule combinations to identify effective compounds for cardiac reprogramming.
- * Co-expression of a single transcription factor, Oct4, with the small-molecule cocktail in mouse fibroblasts.
- * Analysis of resulting cells for cardiac markers, spontaneous contraction, and phenotype.
- * Evaluation of the cells' developmental trajectory, including a cardiac progenitor stage.
Main Results:
- * A defined small-molecule cocktail was identified that efficiently converts mouse fibroblasts into cardiac cells.
- * Reprogramming was achieved using only one transcription factor (Oct4) without inducing pluripotency.
- * The induced cardiomyocytes exhibited spontaneous contraction and a ventricular phenotype.
- * The reprogrammed cells were observed to pass through a cardiac progenitor stage.
Conclusions:
- * Small molecules can significantly enhance cardiac reprogramming efficiency, reducing the need for multiple genetic factors.
- * This small-molecule-driven approach provides a foundation for pharmacological reprogramming strategies in regenerative medicine.
- * The findings offer a new method for generating cardiomyocytes for therapeutic use and mechanistic studies.
More Related Videos
10:05Improved Generation of Induced Cardiomyocytes Using a Polycistronic Construct Expressing Optimal Ratio of Gata4, Mef2c and Tbx5
Published on: November 13, 2015
09:29Assessing Cardiomyocyte Subtypes Following Transcription Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts
Published on: March 22, 2017
Related Concept Videos
Somatic to iPS Cell Reprogramming
Methods of Nuclear Reprogramming